# Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma

> **NCT05842746** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 74 (estimated)

## Conditions studied

- Glioblastoma, IDH-wildtype

## Interventions

- **DRUG:** Elemene
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05842746
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-05
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05842746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05842746, "Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05842746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*